Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis
Background. This research is aimed to explore mortality patterns and quantitatively assess the risks of cardiovascular mortality (CVM) in patients with primary gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Methods. We extracted data from the Surveillance, Epidemiology, and End Results...
Main Authors: | Shenghong Sun, Wei Wang, Chiyi He |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2021/9985814 |
Similar Items
-
Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms
by: Pao-Yuan Huang, et al.
Published: (2018-11-01) -
Research Progress of Gastroenteropancreatic Neuroendocrine Neoplasm
by: LUO Wenhao, et al.
Published: (2018-01-01) -
Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms
by: Justyna Kikut, et al.
Published: (2020-06-01) -
Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
by: Kenta Kawasaki, et al.
Published: (2018-02-01) -
Gastroenteropancreatic neuroendocrine tumor registry study in China
by: Lin Cong, MD, et al.
Published: (2018-12-01)